• Profile
Close

Topical combination of fluorouracil and calcipotriene as palliative therapy for refractory extramammary Paget disease

JAMA Dermatology Feb 24, 2019

Molina GE, et al. - Investigators analyzed 3 females to examine the utility and efficiency of a topical combination of fluorouracil and calcipotriene as palliative treatment for refractory extramammary Paget disease (EMPD) (rare intraepithelial adenocarcinoma) in this retrospective case series. The candidates were instructed to apply 1:1 mixture of fluorouracil, 5%, cream and calcipotriene, 0.005%, cream. They observed clinical improvement in symptoms and lesions in all 3 cases with histopathological signs of decreased tumor burden in 2 cases. They noticed the frequent recurrence of EMPD even after aggressive surgical management. Hence, they suggested palliative topical treatment with combined fluorouracil and calcipotriene as a viable alternative for such cases.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay